Platform Technology Partners
VKTX icon

Platform Technology Partners’s Viking Therapeutics VKTX Stock Holding History

Platform Technology Partners’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$226K Buy
+6,928
New +$240K 0.04% 341
2025
Q3 		– Sell
-9,259
Closed -$245K – 273
2025
Q2 		$245K Buy
+9,259
New +$244K 0.06% 215
2024
Q4 		– Sell
-4,560
Closed -$289K – 236
2024
Q3 		$289K Buy
+4,560
New +$268K 0.09% 182

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Platform Technology Partners's VKTX Position: Q3 2026 in Review

Platform Technology Partners opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 6,928 shares worth $226K. The stake represents 0.04% of the portfolio and ranks #341 among its holdings. This is a return to the name: Platform Technology Partners previously reported a position in VKTX as recently as Q2 2025.

Platform Technology Partners first reported a position in VKTX in Q3 2024 and has held it in 3 quarters since. The position peaked at $289K in Q3 2024. 227 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • Platform Technology Partners held 6,928 shares of Viking Therapeutics worth $226K as of Q3 2026.
  • Viking Therapeutics was a new Platform Technology Partners position in Q3 2026.
  • Viking Therapeutics made up 0.04% of Platform Technology Partners's portfolio in Q3 2026, its #341 holding.
  • Platform Technology Partners first reported a position in Viking Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Platform Technology Partners's Viking Therapeutics position peaked at $289K in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Platform Technology Partners's 13F filing for Q3 2026, filed 2 Nov 2026.